Welcome to our dedicated page for 111 SEC filings (Ticker: YI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking China’s fast-moving digital pharmacy sector is tough. 111 Inc.’s filings weave together health-care regulation, e-commerce logistics and AI investment—leaving investors hunting through dense disclosures for the real story. If you’ve ever asked, “How do I find 111 Inc. insider trading Form 4 transactions or break down its quarterly margins?” you’re in the right place.
Stock Titan turns each document into usable insight. Our AI reads every 10-K, 10-Q and 8-K the moment it hits EDGAR, then delivers clear answers to common searches like “111 Inc. quarterly earnings report 10-Q filing” or “111 Inc. proxy statement executive compensation.”
- Real-time alerts for 111 Inc. Form 4 insider transactions real-time—spot executive stock moves before the market reacts.
- 111 Inc. annual report 10-K simplified—see revenue split between B2B drug distribution and B2C pharmacy sales without wading through footnotes.
- 111 Inc. 8-K material events explained—whether it’s a new hospital partnership or regulatory update, our summaries tell you why it matters.
Need deeper context? Ask a plain-English question—“understanding 111 Inc. SEC documents with AI” or “111 Inc. earnings report filing analysis”—and the platform highlights key risk factors, segment KPIs and cash-flow swings in seconds. From 111 Inc. executive stock transactions Form 4 to payment-cycle trends hidden inside footnotes, our expert layer makes complexity manageable.
Stop scrolling through hundreds of pages. Get 111 Inc. SEC filings explained simply—and make faster, better-informed decisions today.
111, Inc. (YI) disclosures show a company managing liquidity through multiple bank credit facilities and operational measures while reporting improving cash generation. The Group had positive operating cash flows of RMB 263,016 for the year ended December 31, 2024 and maintained a Master Guarantee Facility with RMB 100,000 committed (RMB 50,000 undrawn at issuance). Additional facilities include a credit line up to RMB 30,000 expiring January 2026 and other working-capital arrangements drawn and repaid during 2023–2024.
Other disclosures note segment reporting for B2C and B2B, treatment of marketplace revenue as principal/agent, reverse factoring outstanding RMB nil in 2024 (was RMB 98,109 in 2023), share-based plans and repurchases at subsidiary level, and restricted PRC subsidiary capital of RMB 618,830 and RMB 639,000 not available for distribution.
FAQ
What is the current stock price of 111 (YI)?
What is the market cap of 111 (YI)?
